SPECT imaging of dopamine D2 receptors with 123I-IBZM: initial experience in controls and patients with Parkinson’s syndrome and Wilson’s disease - Tatsch, K; Schwarz, J; Oertel, WH; Kirsch, CM (Nucl Med Commun, 1991)